These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4605265)

  • 21. Studies on delayed hypersensitivity pleural exudates in guinea pigs. I. Demonstration of substances in the cell-free exudate which cause inhibition of mononuclear cell migration in vitro.
    Yamamoto S; Dunn CJ; Willoughby DA
    Immunology; 1976 Apr; 30(4):505-11. PubMed ID: 131779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of MIF-like supernatants by rheumatoid arthritis lymphocytes stimulated by immunoglobulin G.
    Sany J; Mathieu O; Clot J; Mandin J; Serre H
    Rheumatology; 1975; 6():131-8. PubMed ID: 1105742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of macrophage inhibition factor by rat lymphocytes following exposure to isologous liver subcellular membranes.
    McCalmon RT; Pinckard RN; Olson MS
    Clin Immunol Immunopathol; 1975 Mar; 3(4):541-54. PubMed ID: 163716
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of tunicamycin on the molecular heterogeneity of guinea pig migration inhibitory factor.
    Remold HG; Mednis AD
    Cell Immunol; 1982 Jan; 66(1):171-9. PubMed ID: 7044563
    [No Abstract]   [Full Text] [Related]  

  • 26. Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.
    Mizoguchi Y; Ohnishi F; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1981; 16(3):260-7. PubMed ID: 7021301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mechanism of migration inhibition involving components of the coagulation system.
    Meade CJ; Lachmann PJ; Binns RM
    Scand J Immunol; 1976; 5(5):529-39. PubMed ID: 785591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in lymphocyte circulation after administration of antigen.
    Cahill R; Hay JB; Frost H; Trnka Z
    Haematologia (Budap); 1974; 8(1-4):321-34. PubMed ID: 4282368
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors.
    Pick E; Brostoff J; Krejci J; Turk JL
    Cell Immunol; 1970 May; 1(1):92-109. PubMed ID: 5523577
    [No Abstract]   [Full Text] [Related]  

  • 30. Macrophage-lymphocyte interaction: antigen-independent binding of guinea pig lymph node lymphocytes by macrophages.
    Lipsky PE; Rosenthal AS
    J Immunol; 1975 Aug; 115(2):440-5. PubMed ID: 50361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional activation of immune lymphocytes by antigenic stimulation in cell mediated immunity. I. Requirement for macrophages in antigen-induced MIF production by guinea pig immune lymphocytes in vitro.
    Ohishi M; Onoue K
    Cell Immunol; 1975 Jul; 18(1):220-32. PubMed ID: 806355
    [No Abstract]   [Full Text] [Related]  

  • 32. Short-term direct, and macrophage stimulated, bactericidal properties of antigen-activated lymph node cell culture fluids.
    Parish WE; Wardle GR; Cowan SI
    Scand J Respir Dis Suppl; 1974; 89():15-28. PubMed ID: 4137926
    [No Abstract]   [Full Text] [Related]  

  • 33. Production of an immunoglobulin-binding factor (IBF) by antigen-stimulated lymph node lymphocytes.
    Fridman WH; Nelson RA; Liabeuf A
    J Immunol; 1974 Sep; 113(3):1008-16. PubMed ID: 4137896
    [No Abstract]   [Full Text] [Related]  

  • 34. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplified migration inhibition effect.
    Philp JR; Huffman AL; DeChatelet LR; Johnson JE
    Infect Immun; 1980 Aug; 29(2):609-16. PubMed ID: 7011979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte-derived factors affecting cell migration in vitro.
    Bergstrand H
    Allergy; 1979 Apr; 34(2):69-96. PubMed ID: 382903
    [No Abstract]   [Full Text] [Related]  

  • 37. Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. II. Analysis of the macrophage-replacing activity of the LPS-stimulated macrophage culture supernatant in the antigenic activation of purified immune lymphocytes.
    Ohishi M; Onoue K
    Cell Immunol; 1976 Oct; 26(2):295-307. PubMed ID: 788926
    [No Abstract]   [Full Text] [Related]  

  • 38. The mechanism of action of soluble lymphocytic mediators. I. A pulse exposure test for the measurement of macrophage migration inhibitory factor.
    Manheimer S; Pick E
    Immunology; 1973 Jun; 24(6):1027-34. PubMed ID: 4736924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and in vivo effect of antibodies against guinea pig lymphokines.
    Geczy CL; Friedrich W; de Weck AL
    Cell Immunol; 1975 Sep; 19(1):65-77. PubMed ID: 1102116
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.